Cargando…
Assessing the Effectiveness of Direct Data Merging Strategy in Long-Term and Large-Scale Pharmacometabonomics
Because of the extended period of clinic data collection and huge size of analyzed samples, the long-term and large-scale pharmacometabonomics profiling is frequently encountered in the discovery of drug/target and the guidance of personalized medicine. So far, integration of the results (ReIn) from...
Autores principales: | Cui, Xuejiao, Yang, Qingxia, Li, Bo, Tang, Jing, Zhang, Xiaoyu, Li, Shuang, Li, Fengcheng, Hu, Jie, Lou, Yan, Qiu, Yunqing, Xue, Weiwei, Zhu, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391323/ https://www.ncbi.nlm.nih.gov/pubmed/30842738 http://dx.doi.org/10.3389/fphar.2019.00127 |
Ejemplares similares
-
From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine
por: Everett, Jeremy R.
Publicado: (2016) -
Individualized Dosage of Tacrolimus for Renal Transplantation Patients Based on Pharmacometabonomics
por: He, Xiaoying, et al.
Publicado: (2022) -
Discovery of the Consistently Well-Performed Analysis Chain for SWATH-MS Based Pharmacoproteomic Quantification
por: Fu, Jianbo, et al.
Publicado: (2018) -
Pharmacometabonomic association of cyclophosphamide 4‐hydroxylation in hematopoietic cell transplant recipients
por: McCune, Jeannine S., et al.
Publicado: (2022) -
Longitudinal Pharmacometabonomics for Predicting Malignant Tumor Patient Responses to Anlotinib Therapy: Phenotype, Efficacy, and Toxicity
por: Hu, Ting, et al.
Publicado: (2020)